Hua Han Health Industry Holdings Limited 華瀚健康產業控股有限公司
Haw Par Pharmaceuticals Holdings Pte Ltd v Hua Han Health (0587)
HK Court of Appeal, 14-Aug-2019
Hua Han Health's application for leave to appeal is refused.
HK Court of Appeal, 14-Aug-2019
Hua Han Health's application for leave to appeal is refused.
Hua Han Health (0587) v Haw Par Pharmaceuticals Holdings Pte Ltd
HK Court of First Instance, 26-Jul-2019
Leave to appeal is refused.
HK Court of First Instance, 26-Jul-2019
Leave to appeal is refused.
Cypress House Capital Ltd v Hua Han Health (0587)
HK Court of First Instance, 18-Jul-2019
The company's debt to the petitioner was satisfied by Bull's-Eye Ltd, owned by 2 of the directors. Haw Par Corp Ltd is substituted as petitioner, and provisional liquidators are appointed.
HK Court of First Instance, 18-Jul-2019
The company's debt to the petitioner was satisfied by Bull's-Eye Ltd, owned by 2 of the directors. Haw Par Corp Ltd is substituted as petitioner, and provisional liquidators are appointed.
Revealed: SFC probes Chairman, CEO of Hua Han Health (0587), freezes their accounts
The SFC has frozen accounts at 3 brokerages up to HK$3.81bn, the amount raised by HHH in 2015 in an open offer ($3.19bn) and a CB ($0.62bn) issued to Huarong (2799) and CCB (0939). The SFC suspects false or misleading statements and misappropriation of part of the proceeds. (16-Feb-2019)
The SFC has frozen accounts at 3 brokerages up to HK$3.81bn, the amount raised by HHH in 2015 in an open offer ($3.19bn) and a CB ($0.62bn) issued to Huarong (2799) and CCB (0939). The SFC suspects false or misleading statements and misappropriation of part of the proceeds. (16-Feb-2019)
Hua Han Health (0587) gives reasons for SFC's suspension of trading
Company announcement, 21-Nov-2018
"The concerns of the SFC stated in the Rule 8(1) Direction aremainly in relation to the annual reports issued by the Company since 30 June 2012".
Company announcement, 21-Nov-2018
"The concerns of the SFC stated in the Rule 8(1) Direction aremainly in relation to the annual reports issued by the Company since 30 June 2012".
SFC directs suspension of Hua Han Health (0587)
SEHK, 20-Nov-2018
It's been suspended since 27-Sep-2016 when it first missed a results deadline.
SEHK, 20-Nov-2018
It's been suspended since 27-Sep-2016 when it first missed a results deadline.
Hua Han Bio (0587): all 3 INEDs replaced
Company announcement, 24-Jul-2015
All 3 INEDs resigned simultaneously, 2 due to "other personal commitments" and 1 due to "other business commitments", and were immediately replaced.
Company announcement, 24-Jul-2015
All 3 INEDs resigned simultaneously, 2 due to "other personal commitments" and 1 due to "other business commitments", and were immediately replaced.
CSFB's Toxic Convertibles
Webb-site.com lifts the lid on the toxic convertibles scam in HK, in which small, mostly naive companies surrender control over future equity issuance to an investment bank, whose principal interest is to lock in a profit by converting bonds on a rolling basis at a deep discount to market and selling the resulting shares. CSFB has led the way down this value-destroying path, with Merrill Lynch recently joining the fray. We estimate that the banks make a gross profit on money raised of about 31%, and the average stock price has fallen 30% since a toxic convertible was launched. If you are a listed company, just say no. If you are an institutional investor, take your business elsewhere. (8-Jun-2005)
Webb-site.com lifts the lid on the toxic convertibles scam in HK, in which small, mostly naive companies surrender control over future equity issuance to an investment bank, whose principal interest is to lock in a profit by converting bonds on a rolling basis at a deep discount to market and selling the resulting shares. CSFB has led the way down this value-destroying path, with Merrill Lynch recently joining the fray. We estimate that the banks make a gross profit on money raised of about 31%, and the average stock price has fallen 30% since a toxic convertible was launched. If you are a listed company, just say no. If you are an institutional investor, take your business elsewhere. (8-Jun-2005)
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy